​

Alumis (ALMS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Alumis Revenue Highlights

Latest Revenue (Y)

$24.05M

Latest Revenue (Q)

$1.66M

Main Segment (Y)

License

Alumis Revenue by Period

Alumis Revenue by Year

DateRevenueChange
2025-12-31$24.05M100.00%
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--

Alumis generated $24.05M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Alumis Revenue by Quarter

DateRevenueChange
2026-06-30$1.66M-4.54%
2026-03-31$1.74M-9.75%
2025-12-31$1.93M-6.63%
2025-09-30$2.07M-22.51%
2025-06-30$2.67M-84.67%
2025-03-31$17.39M100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--

Alumis generated $1.66M in revenue during Q2 2026, up -4.54% compared to the previous quarter, and up 9.56% compared to the same period a year ago.

Alumis Revenue Breakdown

Alumis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
Collaboration Revenue$6.66M
License$17.39M

Alumis's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (72.30%), and Collaboration Revenue (27.70%).

Quarterly Revenue by Product

Product/ServiceJun 26Mar 26Dec 25Sep 25Jun 25
Collaboration Revenue$1.66M$1.74M$1.93M$2.07M$2.67M
License---$17.39M$17.39M

Alumis's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Collaboration Revenue (100.00%).

Alumis Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RIGLRigel Pharmaceuticals$294.28M$78.70M
ANABAnaptysBio$234.60M$25.56M
ALMSAlumis$24.05M$1.66M
ACRSAclaris Therapeutics$7.83M$1.63M
ODTXOdyssey Therapeutics$2.98M-
IFRXInflaRx$61.80K$36.25K
AVTXAvalo Therapeutics$59.00K-
AGMBAgomAb Therapeutics N.V. American Depositary Shares--
ALDXAldeyra The--
TLSATiziana Life Sciences--
ARTVArtiva Biotherapeutics--

ALMS Revenue FAQ

What is Alumis’s yearly revenue?

Alumis's yearly revenue for 2025 was $24.05M, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. ALMS's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Alumis’s quarterly revenue?

Alumis's quarterly revenue for Q2 2026 was $1.66M, a -4.54% decrease from the previous quarter (Q1 2026), and a -37.66% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $1.74M, a -9.75% decrease from the previous quarter (Q4 2025), and a -89.99% decrease year-over-year (Q1 2025). ALMS's quarterly revenue for Q4 2025 was $1.93M, a -6.63% decrease from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Alumis’s revenue growth rate?

Alumis's revenue growth rate for the last 3 years (2023-2025) was 0%

What are Alumis’s revenue streams?

Alumis's revenue streams in c 25 are Collaboration Revenue, and License. Collaboration Revenue generated $6.66M in revenue, accounting 27.70% of the company's total revenue License generated $17.39M in revenue, accounting 72.30% of the company's total revenue

What is Alumis’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Alumis was License. This segment made a revenue of $17.39M, representing 72.30% of the company's total revenue.